On 6 August 2026, the Union Cabinet approved GOBARdhan, India's National Circular Bioenergy Scheme, with an outlay of ₹23,731 crore running from FY2026-27 to FY2035-36. It targets nearly ten-fold growth in domestic compressed biogas production and folds together what used to be scattered support for manure sales, machinery and pipeline infrastructure into one scheme. For anyone considering a biotechnology business built around biogas, vermicompost or organic manure, this is as direct a government signal as this sector gets: a single national scheme, freshly funded, aimed squarely at the waste-to-value chain these businesses sit inside.
That announcement did not arrive in isolation. It follows the NITI Aayog roadmap released weeks earlier, in July 2026, projecting India's bioeconomy to grow from $195.3 billion in 2025 to $691 billion by 2035 — a trajectory that names industrial enzymes and biomanufacturing among its core growth engines. Two national-level policy moves inside the same month is not a coincidence for a founder to ignore.
|
At a Glance: Starting a Biotechnology Business in India
• India's bioeconomy: $195.3 billion in 2025, targeted to reach $691 billion by 2035 (NITI Aayog, July 2026)
• Fresh national scheme: GOBARdhan, ₹23,731 crore for compressed biogas and organic manure, approved 6 August 2026
• Minimum investment: a small vermicompost or biogas unit can start under ₹10-25 lakh; an enzyme production unit needs considerably more (industry estimate)
• Key manufacturing states: Maharashtra, Gujarat, Karnataka, Tamil Nadu, Punjab (agro-processing and dairy clusters)
• Key licence: FSSAI for food/feed enzymes, Fertilizer Control Order registration for biofertilizers, MoEFCC clearance for biogas plants
• Regulatory bodies to know: Department of Biotechnology (DBT) and BIRAC for R&D-linked funding and incubation support
|
Why This Is One of the Best Manufacturing Opportunities Right Now
The strongest argument for entering industrial biotechnology now is that this is one of the few manufacturing sectors where the raw material is waste, the demand is regulatory as well as commercial, and the government has just put fresh money behind the value chain. GOBARdhan alone creates an assured-demand structure: a Market Development Assistance payout of ₹1,500 per tonne applies to Fermented Organic Manure, Liquid FOM and Phosphate Rich Organic Manure sold by registered plants, plus a 3% interest subsidy on loans up to ₹2 crore for seven years through the Agriculture Infrastructure Fund for larger projects.
|
Surprising stat: By July 2026, only around 217 compressed biogas plants were operational nationwide with a combined output of about 1,773 tonnes a day — against a scheme designed to grow production nearly ten-fold. The infrastructure gap this signals is exactly where new entrants fit.
|
Second, the PM-PRANAM scheme, extended to every state and union territory from August 2024, redirects fertilizer subsidy savings back to states that cut chemical fertilizer use in favour of organic and biofertilizer alternatives — a policy structure that pushes state governments themselves to actively promote the products a biofertilizer manufacturer sells. Third, enzymes: DBT and BIRAC have run joint calls specifically for 'Biomanufacturing of Enzymes' under the BioE3 Policy, targeting indigenous, affordable enzyme production to replace imports — a founder-relevant funding channel that did not exist before 2024.
Entry economics also favour smaller players in this sector more than most manufacturing categories. Vermicomposting needs little more than composting pits, organic waste feedstock and worm culture, while a household or cooperative-scale biogas plant can now draw on GOBARdhan's capital and offtake support from day one — this is a sector where the lowest-capital entry point is also the one currently receiving the newest government funding.
Market Demand, Growth and Statistical Evidence
India's bioeconomy has compounded fast: from $10 billion in 2014 to $165.7 billion by the end of 2024, and $195.3 billion in 2025, a roughly 18% annual growth rate that NITI Aayog's own roadmap documents. Within that, the BioIndustrial segment — which the roadmap explicitly defines to include enzymes, fermentation platforms and biopolymers — is projected to grow from $180.4 billion in 2030 to $318 billion by 2035, the fastest-scaling bucket after biopharma.
|
Year
|
India Bioeconomy Value
|
Basis
|
|
2014
|
$10 billion
|
NITI Aayog roadmap (actual)
|
|
2024
|
$165.7 billion
|
DBT / BIRAC Indian Bioeconomy Report 2025 (actual)
|
|
2025
|
$195.3 billion (4.8% of GDP)
|
NITI Aayog roadmap, July 2026 (actual)
|
|
2030 (est.)
|
BioIndustrial segment alone: $180.4 billion
|
NITI Aayog roadmap, July 2026
|
|
2035 (est.)
|
Overall bioeconomy: $691 billion; BioIndustrial segment: $318 billion
|
NITI Aayog roadmap, July 2026
|
Demand for the specific sub-segments in this guide is driven by different buyers: enzymes sell into food processing, textiles, detergents and animal feed manufacturers looking to cut chemical inputs; biofertilizers and vermicompost sell into a farming base being actively steered away from chemical fertilizer subsidy dependence; and biogas output sells into both the rural cooking-fuel market and, increasingly, the compressed natural gas grid as blending mandates rise.
What Government Data Tells Entrepreneurs About This Sector
Government commitment here spans multiple departments rather than one scheme. The Department of Biotechnology and BIRAC jointly run 94 bioincubators across 25 states and union territories as of 2026, alongside 9 biotech parks and 4 biotech science clusters, giving a new founder access to shared infrastructure without building a full lab from scratch. The BioE3 Policy's Bio-RIDE component, approved alongside it in August 2024, carries a ₹9,197-crore outlay through FY2025-26 for biomanufacturing and biofoundry support.
|
Data Point
|
Figure
|
Source / Year
|
|
GOBARdhan National Circular Bioenergy Scheme outlay
|
₹23,731 crore, FY2026-27 to FY2035-36
|
Union Cabinet, 6 August 2026
|
|
Market Development Assistance on organic manure (FOM/LFOM/PROM)
|
₹1,500 per tonne
|
GOBARdhan scheme guidelines, 2026
|
|
DBT-BIRAC bioincubator network
|
94 bioincubators across 25 states/UTs
|
DBT/BIRAC, 2026
|
|
Bio-RIDE Biomanufacturing & Biofoundry outlay
|
₹9,197 crore, FY2021-22 to FY2025-26
|
Union Cabinet / DBT, 2024
|
The practical takeaway: unlike sectors where government support is a single scheme with one application window, this one has parallel entry points depending on which sub-segment a founder chooses — GOBARdhan for biogas and manure, PM-PRANAM's state-level push for biofertilizers, and DBT-BIRAC funding calls for enzyme technology. Matching the right scheme to the right product line matters more here than in most manufacturing categories.
Government Schemes, Incentives and Support Facilities
Beyond GOBARdhan and PM-PRANAM, standard MSME support applies fully: Udyam registration opens CGTMSE collateral-free credit and PMEGP capital subsidy for a small vermicompost, biofertilizer or enzyme unit. Founders working on genuinely novel enzyme formulations or biomaterials should apply directly to DBT-BIRAC funding calls, which support both academic-industry and pure industry proposals, with industry applicants required to hold at least 51% Indian shareholding.
At the state level, Gujarat's dairy cooperative network — Amul, Banas Dairy, Dudhsagar Dairy — is actively partnering on new household biogas installations under GOBARdhan, a model other dairy-heavy states are expected to replicate. Punjab, Maharashtra and Karnataka similarly offer cluster-level support for agro-waste-based units through their state MSME departments, and the Agriculture Infrastructure Fund's 3% interest subsidy applies nationally to larger biogas and manure-processing projects.
The Import-Export Opportunity
Enzymes are the clearest import-substitution story in this sector: India currently imports a meaningful share of specialty industrial enzymes despite having the biological research base to manufacture them domestically, which is exactly the gap DBT-BIRAC's enzyme biomanufacturing call is designed to close. A founder building indigenous enzyme capacity is positioned against imports rather than against other domestic competitors, a materially easier competitive position.
Biofertilizers and organic manure remain largely domestic-demand businesses for now, given transport costs and the sheer scale of India's own farming base, though export interest is emerging from countries tightening their own chemical fertilizer regulations. Biogas, by contrast, is not an export product in the conventional sense — it is a domestic energy-security play, and GOBARdhan's explicit goal of cutting reliance on imported fossil gas is itself a form of import substitution.
Major Indian Players
|
Company / Type
|
Segment
|
Notes
|
|
Advanced Enzymes Technologies
|
Industrial & specialty enzymes
|
One of India's larger listed enzyme manufacturers, food and pharma applications
|
|
National Dairy Development Board (NDDB)-linked cooperatives
|
Biogas / organic manure
|
Partnering on household biogas rollouts under GOBARdhan in Gujarat
|
|
IFFCO
|
Biofertilizers
|
Major cooperative producer expanding nano and bio-fertilizer lines
|
|
Regional vermicompost MSMEs
|
Vermicompost
|
Cluster-scale units near urban organic-waste and agricultural belts
|
|
Compressed biogas project developers (various)
|
CBG plants
|
217 plants operational nationwide as of mid-2026, hundreds more under construction
|
The Growth Horizon: Outlook to 2035
Taking NITI Aayog's stated trajectory as the reference case — an official projection, not a guarantee — India's overall bioeconomy is expected to more than triple from $195.3 billion in 2025 to $691 billion by 2035, with the BioIndustrial segment that houses enzymes and biomanufacturing nearly doubling between 2030 and 2035 alone. Within that, GOBARdhan's ten-fold compressed biogas production target and PM-PRANAM's continuing push against chemical fertilizer dependence give the biogas and biofertilizer sub-segments a specific, funded, near-decade runway rather than a vague long-range forecast.
For a business started today, the strongest position is one that can plug directly into a named scheme — a GOBARdhan-registered biogas or manure unit, or a DBT-BIRAC-backed enzyme project — rather than one operating purely on organic market demand. Schemes with defined funding windows and offtake assurance reduce the two biggest risks in this sector: capital access and buyer uncertainty.
|
Practitioner Insight: Vermicompost and biogas entrepreneurs often underestimate feedstock logistics. A plant sized for a fixed daily tonnage of cattle dung or agri-residue can sit idle for want of aggregation infrastructure — lock in a feedstock supply agreement with a dairy cooperative or agri-cluster before finalising plant capacity, not after.
|
Practitioner Q&A: What Founders Actually Ask
Which is the lowest-capital entry point into industrial biotechnology?
Vermicomposting, since it needs composting pits, organic waste and worm culture rather than processing machinery — most founders use it as a stepping stone into biofertilizer manufacturing once cash flow builds.
How does GOBARdhan actually help a new biogas plant financially?
It offers Market Development Assistance of ₹1,500 per tonne on registered organic manure sales, plus access to a 3% interest subsidy on loans up to ₹2 crore through the Agriculture Infrastructure Fund for larger projects.
Do I need FSSAI approval to manufacture industrial enzymes?
Only for food and feed enzymes specifically — FSSAI regulates that category, while other industrial applications fall under different quality and safety norms depending on end use.
Is biofertilizer manufacturing actually profitable given low product prices?
Margins depend on scale and feedstock cost control, but PM-PRANAM's state-level incentive structure is designed to grow the buyer base for biofertilizers specifically, which supports volume growth even where per-unit margins stay thin.
Can a small enzyme startup access DBT-BIRAC funding directly?
Yes, provided the company holds at least 51% Indian shareholding and submits a proposal through BIRAC's call process, with project funding available for up to two years, extendable to five based on performance.
What's driving fresh demand for compressed biogas specifically?
Rising CNG and piped natural gas blending mandates, combined with GOBARdhan's assured offtake framework, are creating a structured buyer pipeline that did not exist for most of the sector's earlier history.
Is vermicompost or chemical-free organic manure export-viable?
Not primarily — this remains a domestic-demand business for now, given transport economics and the scale of India's own farming sector, though selective export interest is emerging from countries tightening fertilizer regulation.
What licence do I need first for a biogas plant?
Environmental clearance under Ministry of Environment, Forest and Climate Change norms is the starting point, followed by registration on the GOBARdhan portal to access Market Development Assistance and other scheme benefits.
How risky is feedstock supply for a new biogas or vermicompost unit?
It is the most underestimated risk in this sector — secure a feedstock supply agreement with a dairy cooperative, agri-cluster or municipal waste source before sizing your plant, not after committing capital.
Which states currently offer the strongest support for this business?
Gujarat leads on biogas through its dairy cooperative partnerships, while Maharashtra, Karnataka and Punjab offer strong cluster-level support for agro-waste-based biotechnology units through their state MSME departments.
The Bottom Line
The single strongest reason to enter industrial biotechnology now is timing: GOBARdhan's ₹23,731-crore national scheme was approved in August 2026, PM-PRANAM already redirects state fertilizer subsidies toward organic alternatives, and DBT-BIRAC is actively funding indigenous enzyme development — three separate, currently active funding channels aimed at the exact sub-segments this sector covers.
Government support is genuinely multi-agency: the Ministry of Petroleum and Natural Gas administers GOBARdhan, the Department of Fertilisers runs PM-PRANAM, and the Department of Biotechnology with BIRAC funds enzyme and biomanufacturing R&D, giving founders more than one door to knock on depending on their chosen product line.
The realistic trajectory is strong and funded rather than merely promising, with India's bioeconomy tracking an 18%-plus annual growth rate that NITI Aayog's own roadmap now targets extending to $691 billion by 2035.
The practical first step is to pick one sub-segment — biogas, biofertilizer, vermicompost or enzymes — register on the relevant scheme portal (GOBARdhan for biogas and manure) before finalising plant capacity, and lock in feedstock supply agreements early, since that is where most new entrants in this sector actually stumble.
References
• NITI Aayog — Roadmap for Building India as a Leading BioEconomy Powerhouse by 2035 (July 2026)
• Prime Minister's Office, Government of India — Cabinet approval of the GOBARdhan National Circular Bioenergy Scheme (August 2026)
• Department of Biotechnology (DBT) and BIRAC, Government of India — Bio-RIDE scheme and enzyme biomanufacturing funding calls
• India Brand Equity Foundation (IBEF) — PM-PRANAM scheme and GOBARdhan scheme details
• Ministry of MSME, Government of India — CGTMSE and PMEGP scheme provisions
• Press Information Bureau (PIB), Government of India — BioE3 Policy Cabinet approval
